Life Sciences: Experience

CORPORATE and M&A

Nabriva Therapeutics on the proposed redomicile of its holding company from Austria to Ireland, by means of an exchange offer.
Sale of Creganna to TE Connectivity for $895m.
Endo Health Solutions on its $1.6bn acquisition of Paladin Labs and related Corporate Inversion into Ireland; its subsequent acquisition of Auxilium for $2.6bn and of Par Pharmaceuticals for $8.05bn, together with its capital markets fund raising of $2bn and its debt note offering of $1.5bn.
Aralez Pharmaceuticals on setting up its Irish structure and the subsequent acquisition of various product rights, including Zontivity and Toprol-XL.
Pfizer on its proposed $160bn merger with Allergan.
Medtronic on its $49bn acquisition of Covidien.
Jazz Pharmaceuticals on the reverse takeover of Azur Pharma and corporate inversion of the NASDAQ listed Jazz entity to Ireland.
Vidara Therapeutics on the acquisition of Irish listed pharmaceutical company AGI Therapeutics and subsequently on its merger with Horizon Pharma.
Pfizer on its proposed $160bn merger with Allergan plc.
UDG on the €407m sale of its pharmaceutical distribution businesses to global pharmaceutical wholesaler McKesson.
Perrigo Company on its defence of the hostile offer by Mylan N.V.
Pozen on its proposed acquisition of Tribute Pharmaceuticals and setting up its Irish structure.
élan on its formal sale process and Perrigo Company's recommended $8.6bn takeover offer.
élan on its successful defence of the hostile $6.7bn offer by Royalty Pharma for élan.
GenCell Biosystems on its acquisition by Becton, Dickinson and Company.
Vidara Therapeutics on the acquisition of Irish listed pharmaceutical company AGI Therapeutics and subsequently on its proposed merger with Horizon Pharma and related inversion to Ireland.
élan on the sale of EDT to Alkermes Inc and Alkermes' related corporate inversion into Ireland.
Greatbatch on its acquisition of Lake Region Medical.
Air Liquide on its acquisition of Baywater Healthcare Ireland.
Malin on its investments in Immunocore, Altan Pharma 3D4Medical.
Permira on the acquisition of Creganna Tactx Medical.
Deutsche Bank as financial adviser on Warner Chilcott's acquisition by Actavis.
IPOS in its sale of pharmacy interests to UniPhar.
Catalent Pharma Solutions on its acquisition by Clondalkin Group.
Icon on its acquisition of Firecrest, Oxford Outcomes and the clinical trials division of Cross Country Healthcare.
Vention Medical on the acquisition of Ansamed, Ireland’s premier provider of advanced medical tubing solutions.

EQUITY CAPITAL MARKETS

Malin Corporation plc on its latest private placement equity fundraising (May 2017).
Perrigo on its acquisition of Omega Pharma and related $1bn equity offering.
Medtronic on its $49bn acquisition of Covidien and the subsequent $105bn listing of a new Irish holding company (Medtronic plc) on the NYSE.
Endo on its $2.3bn equity offering.
Oneview Healthcare on its €40m IPO and admission to the Official List of the Australian Securities Exchange.
Malin Corporation on its €42m private placement.
Jazz Pharmaceuticals on its IPO on NASDAQ.
Jazz Pharmaceuticals on the $390m secondary offering by certain shareholders and on a $200m share buyback programme on NASDAQ.
élan on its underwritten disposal of a $550m stake in Alkermes.
élan on its $1bn “Dutch Auction” tender offer share buyback.

COMMERCIAL CONTRACTS & AGREEMENTS

Syntec Scientific on its distribution arrangements with Roche Diagnostics.
Various clients in preparing research agreements and collaboration agreements.
Board of directors of various Irish hospitals and pharma entities on corporate governance, corporate restructuring, commercial contracts and other director related issues.
Biovail Corporation/Valeant Pharmaceuticals in relation to negotiating a warehousing and distribution agreement with DHL Excel.
Novartis Animal Health in preparing and negotiating a distribution agreement with Allphar Services Limited.
Various distributors and agents in relation to termination of multiple distribution and agency agreements.
An international pharma client in the establishment of various foreign representative officers and branches for overseas distribution.
A multinational pharma company preparing (i) contract manufacturing and quality agreements for API Contract Manufacturing; (ii) utilities purchase agreements; (iii) amendments to global logistics supplier master agreements; (iv) shared services and manufacturing agreements; and (vi) advising on parallel trade import issues and product labelling requirements.
Various clients in preparing research agreements and collaboration agreements.
Royal College of Surgeons on various commercial transactions including a long term outsourced services and intellectual property licensing contract in respect of a new academic medical teaching hospital in Kuala Lumpur, Malaysia.
Merit Healthcare on the outsourcing of accommodation for the provision of primary healthcare in Ireland.
Becton Dickinson a leading global medical technology company on software licensing.
Baxter Healthcare on the provision of Oncology services based on a concession model, to Antrim Hospital.
A wide range of pharmaceutical companies in preparing and negotiating wholesale distribution agreements and warehousing and distribution agreements with various parties including Movianto Ireland.
A pharmaceutical multinational in preparing and negotiating pharmacovigilance agreements with various distributors.

PATENT LITIGATION

Boston Scientific on the Irish defence of patent proceedings brought by Edwards Lifesciences PVT in the Commercial Court relating to the infringement of a patent concerning transcatheter heart valves.
Pfizer in the Irish defence of a complex multi-jurisdictional patent action brought by GlaxoSmithKline Biologicals SA in the Commercial Court relating the infringement of four patents concerning meningitis B vaccines and their commercialisation.
Baxter Healthcare in the defence of a Commercial Court patent infringement action taken by Fresenius Medical Care relating to a dialysis treatment product.
Amgen on the Irish stream of its defence of infringement and entitlement High Court proceedings in a multi-jurisdictional pharma patent dispute against Teva Pharma BV.
AstraZeneca in relation to a significant Commercial Court patent revocation action brought by Teva for a leading asthma drug and a related Supreme Court appeal.
Abbott Laboratories and Guidant Corporation in their defence of a multi-million euro global claim by Medtronics Corporation relating to the design and development of cardiovascular medical products.

REGULATORY

Aspen Pharmaceuticals Holdings on a legislative compliance project in respect of Aspen Pharmaceutical Trading Ltd. The project involved the preparation of legislative summaries and regulatory compliance check-lists covering all of the legal obligations of the Irish subsidiary in the pharmaceutical regulatory areas, and in other areas including tax, environmental, employment, and competition.
An international company specialising in the manufacture of vaccines on a compliance matrix, stating the legal and industry requirements in Ireland when interacting with healthcare professionals in the area of consulting, educational events, corporate gifts and donations and sponsorship.
A multi-national manufacturer of medical devices on all of the regulatory requirements referable to medical devices in the Irish sector.
An Irish manufacturer of high potency drugs, on a potential regulatory investigation and enforcement action by the Irish Medicines Board as a consequence of allegations made by an employee with regard to the alleged improper use of a potentially teratogenic high potency drug. The Firm also advised on the employment aspects arising in respect of this issue.
Baxter Healthcare on various regulatory aspects of the regulation of blood and blood products.